v3.26.1
Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series AA Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series AAA Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series AAA Convertible Junior Preferred Stock [Member]
Preferred Stock [Member]
Series C Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Series AA Convertible Preferred Stock [Member]
Common Stock [Member]
Series AAA Convertible Preferred Stock [Member]
Common Stock [Member]
Series AAA Convertible Junior Preferred Stock [Member]
Common Stock [Member]
Shares Including Commitment Shares [Member]
Equity Purchase Agreement [Member]
Common Stock [Member]
Commitment Shares [Member]
Equity Purchase Agreement [Member]
Common Stock [Member]
Series A, AA, and AAA Convertible Preferred Stock [Member]
Common Stock [Member]
Pipe Pre-Funded Warrants [Member]
Common Stock [Member]
Melon Acquisition [Member]
Common Stock [Member]
Superbiz Acquisition [Member]
Common Stock [Member]
Misfits Purchase Agreement [Member]
Common Stock [Member]
Hide or OOF! [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Series C Preferred Stock [Member]
Additional Paid-in Capital [Member]
Shares Including Commitment Shares [Member]
Equity Purchase Agreement [Member]
Additional Paid-in Capital [Member]
Commitment Shares [Member]
Equity Purchase Agreement [Member]
Additional Paid-in Capital [Member]
Misfits Pre-Funded Warrant [Member]
Additional Paid-in Capital [Member]
Misfits Warrant [Member]
Additional Paid-in Capital [Member]
Melon Acquisition [Member]
Additional Paid-in Capital [Member]
Misfits Purchase Agreement [Member]
Additional Paid-in Capital [Member]
Hide or OOF! [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Series C Preferred Stock [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Equity Purchase Agreement [Member]
Total
Balance, end of period           $ 0                         $ 0                 $ 270,205,000   $ (270,035,000) $ 0    
Total stockholders’ (deficit) equity           $ 0                         $ 0                 270,205,000   (270,035,000) 0    
Balance, beginning of period (in shares) at Dec. 31, 2024           17,499                         33,801                            
Balance, end of period (in shares) at Mar. 31, 2025           16,669                         37,145                            
Balance, beginning of period at Dec. 31, 2024           $ 0                         $ 0                 270,205,000   (270,035,000) 0    
Balance, end of period at Mar. 31, 2025           $ 0                         $ 0                 270,805,000   (274,266,000) 0    
Balance, beginning of period (in shares) at Dec. 31, 2024           17,499                         33,801                            
Issuance of shares, conversion of convertible securities (in shares) 0 (840) (150) (83) 0   (147) (67) (187) (139)                                              
Balance, end of period (in shares) at Jun. 30, 2025           16,426                         73,729                            
Balance, beginning of period at Dec. 31, 2024           $ 0                         $ 0                 270,205,000   (270,035,000) 0    
Fair value, conversion of convertible securities $ 0 $ 0 $ 0 $ 0 $ 0               $ 0                                        
Balance, end of period at Jun. 30, 2025           0                         $ 0                 273,032,000   (277,149,000) 0   $ (4,117,000)
Issuance of shares, warrants exercised (in shares)                           0                                      
Issuance of shares (in shares)                     1,494 625             33,129                            
Common stock issued for Acquisition (in shares)                             75 547 0                                
Preferred stock dividends paid – common stock (in shares)                                     663                            
Issuance of shares, conversion of convertible securities (in shares) (0) 840 150 83 (0)   147 67 187 139                                              
Issuance of fractional shares – January 2026 Reverse Split (in shares)                                     0                            
Stock-based compensation (in shares)                                     2,827                            
Common stock issued for Asset Acquisition (in shares)                                   0                              
Other (in shares)                                     28                            
Fair value, warrants exercised                           $ 0                                      
Issuance of shares                     $ 0               $ 0   $ 232,000 $ 138,000           1,561,000          
Reverse stock split                                     0                            
Preferred stock dividends paid                                     0                 101,000         101,000 [1]
Common stock issued for Acquisition                             $ 0 $ 0 $ 0               $ 8,000 $ 0              
Stock-based compensation                                     0                 556,000          
Issuance of common stock in settlement of legal matter                                     0                            
Redemption of Series C preferred stock                                       $ 0                          
Deemed dividend - Down round                                                       0   0     0
Adjustments to additional paid in capital, warrant issued                                             $ 0 $ 0                  
Prepaid consultant costs and other                                                       231,000          
Common stock issued for Asset Acquisition                                                     $ 0            
Preferred stock dividends paid – common stock                                                           (101,000)      
Deemed dividend – Series C redemption                                                         $ 0       0
Net loss                                                           (7,013,000)     (7,013,000)
Unrealized loss on available-for-sale securities                                                             0   0
Balance, end of period           0                         0                 270,805,000   (274,266,000) 0    
Total stockholders’ (deficit) equity           $ 0                         $ 0                 270,805,000   (274,266,000) 0    
Balance, beginning of period (in shares) at Mar. 31, 2025           16,669                         37,145                            
Issuance of shares, conversion of convertible securities (in shares) 0 (60) (100) (83) 0   0 (67) (125) (139)                                              
Balance, end of period (in shares) at Jun. 30, 2025           16,426                         73,729                            
Balance, beginning of period at Mar. 31, 2025           $ 0                         $ 0                 270,805,000   (274,266,000) 0    
Fair value, conversion of convertible securities $ 0 $ 0 $ 0 $ 0 $ 0               0                                        
Balance, end of period at Jun. 30, 2025           0                         $ 0                 273,032,000   (277,149,000) 0   (4,117,000)
Issuance of shares, warrants exercised (in shares)                           0                                      
Issuance of shares (in shares)                     0 0             33,133                         1,494  
Common stock issued for Acquisition (in shares)                             75 0 0                                
Preferred stock dividends paid – common stock (in shares)                                     658                            
Issuance of shares, conversion of convertible securities (in shares) (0) 60 100 83 (0)   0 67 125 139                                              
Issuance of fractional shares – January 2026 Reverse Split (in shares)                                     0                            
Stock-based compensation (in shares)                                     2,362                            
Common stock issued for Asset Acquisition (in shares)                                   0                              
Other (in shares)                                     25                            
Fair value, warrants exercised                           $ 0                                      
Issuance of shares                     $ 0               $ 0   0 0           1,561,000          
Reverse stock split                                     0                            
Preferred stock dividends paid                                     0                 100,000          
Common stock issued for Acquisition                             $ 0 $ 0 $ 0               8,000 0              
Stock-based compensation                                     0                 327,000          
Issuance of common stock in settlement of legal matter                                     0                            
Redemption of Series C preferred stock                                       0                          
Deemed dividend - Down round                                                       0   0     0
Adjustments to additional paid in capital, warrant issued                                             0 0                  
Prepaid consultant costs and other                                                       231,000          
Common stock issued for Asset Acquisition                                                     0            
Preferred stock dividends paid – common stock                                                           (100,000)      
Deemed dividend – Series C redemption                                                         0       0
Net loss                                                           (2,783,000)     (2,783,000)
Unrealized loss on available-for-sale securities                                                             0   0
Balance, end of period           0                         0                 273,032,000   (277,149,000) 0   (4,117,000)
Total stockholders’ (deficit) equity           0                         0                 273,032,000   (277,149,000) 0   (4,117,000)
Balance, end of period           0                         1,000                 307,495,000   (289,962,000) 0   17,534,000
Total stockholders’ (deficit) equity           $ 0                         $ 1,000                 307,495,000   (289,962,000) 0   17,534,000
Balance, beginning of period (in shares) at Dec. 31, 2025           98,636                         1,129,901                            
Balance, end of period (in shares) at Mar. 31, 2026           1,223                         1,466,623                            
Balance, beginning of period at Dec. 31, 2025           $ 0                         $ 1,000                 307,495,000   (289,962,000) 0   17,534,000
Balance, end of period at Mar. 31, 2026           $ 0                         $ 2,000                 308,856,000   (294,266,000) (49,000)    
Balance, beginning of period (in shares) at Dec. 31, 2025           98,636                         1,129,901                            
Issuance of shares, conversion of convertible securities (in shares) 0 (50) (20) (97,413) (1,153)   0 (596) (238) (1,655)                                              
Balance, end of period (in shares) at Jun. 30, 2026           0                         1,668,082                            
Balance, beginning of period at Dec. 31, 2025           $ 0                         $ 1,000                 307,495,000   (289,962,000) 0   17,534,000
Fair value, conversion of convertible securities $ 0 $ 0 $ 0 $ 0 $ 0               0                                        
Balance, end of period at Jun. 30, 2026           0                         $ 2,000                 312,214,000   (299,231,000) (80,000)   12,905,000
Issuance of shares, warrants exercised (in shares)                           329,011                                      
Issuance of shares (in shares)                     0 0             0                            
Common stock issued for Acquisition (in shares)                             0 0 26,768                                
Preferred stock dividends paid – common stock (in shares)                                     34,575                            
Issuance of shares, conversion of convertible securities (in shares) (0) 50 20 97,413 1,153   0 596 238 1,655                                              
Issuance of fractional shares – January 2026 Reverse Split (in shares)                                     59,032                            
Stock-based compensation (in shares)                                     81,980                            
Common stock issued for Asset Acquisition (in shares)                                   4,326                              
Other (in shares)                                     0                            
Fair value, warrants exercised                           $ 1,000                                      
Issuance of shares                     $ 0               $ 0   0 0                      
Reverse stock split                                     0                            
Preferred stock dividends paid                                     0                 253,000          
Common stock issued for Acquisition                             $ 0 $ 0 $ 0               0 105,000              
Stock-based compensation                                     0                 2,031,000          
Issuance of common stock in settlement of legal matter                                     0                            
Issuance of shares                                                       (5,000)          
Redemption of Series C preferred stock                                       (1,349,000)                          
Deemed dividend - Down round                                                       1,002,000   (1,002,000)     (1,002,000)
Adjustments to additional paid in capital, warrant issued                                             2,003,000 642,000                  
Prepaid consultant costs and other                                                       0          
Common stock issued for Asset Acquisition                                                     37,000            
Preferred stock dividends paid – common stock                                                           (253,000)      
Deemed dividend – Series C redemption                                                         427,000       427,000
Net loss                                                           (8,441,000)     (8,441,000)
Unrealized loss on available-for-sale securities                                                             (80,000)   (80,000)
Balance, end of period           0                         2,000                 308,856,000   (294,266,000) (49,000)    
Total stockholders’ (deficit) equity           $ 0                         $ 2,000                 308,856,000   (294,266,000) (49,000)    
Balance, beginning of period (in shares) at Mar. 31, 2026           1,223                         1,466,623                            
Issuance of shares, conversion of convertible securities (in shares) 0 (50) (20) 0 (1,153)   0 (596) (238) 0                                              
Balance, end of period (in shares) at Jun. 30, 2026           0                         1,668,082                            
Balance, beginning of period at Mar. 31, 2026           $ 0                         $ 2,000                 308,856,000   (294,266,000) (49,000)    
Fair value, conversion of convertible securities $ 0 $ 0 $ 0 $ 0 $ 0               $ 0                                        
Balance, end of period at Jun. 30, 2026           0                         $ 2,000                 312,214,000   (299,231,000) (80,000)   12,905,000
Issuance of shares, warrants exercised (in shares)                           139,167                                      
Issuance of shares (in shares)                     0 0             0                            
Common stock issued for Acquisition (in shares)                             0 0 26,768                                
Preferred stock dividends paid – common stock (in shares)                                     0                            
Issuance of shares, conversion of convertible securities (in shares) (0) 50 20 (0) 1,153   0 596 238 0                                              
Issuance of fractional shares – January 2026 Reverse Split (in shares)                                     0                            
Stock-based compensation (in shares)                                     34,690                            
Common stock issued for Asset Acquisition (in shares)                                   0                              
Other (in shares)                                     0                            
Fair value, warrants exercised                           $ 0                                      
Issuance of shares                     $ 0               $ 0   $ 0 $ 0           0          
Reverse stock split                                     0                            
Preferred stock dividends paid                                     0                 0          
Common stock issued for Acquisition                             $ 0 $ 0 $ 0               $ 0 $ 105,000              
Stock-based compensation                                     0                 955,000          
Issuance of common stock in settlement of legal matter                                     0                            
Redemption of Series C preferred stock                                       $ (1,349,000)                          
Deemed dividend - Down round                                                       1,002,000   (1,002,000)     (1,002,000)
Adjustments to additional paid in capital, warrant issued                                             $ 2,003,000 $ 642,000                  
Prepaid consultant costs and other                                                       0          
Common stock issued for Asset Acquisition                                                     $ 0            
Preferred stock dividends paid – common stock                                                           0      
Deemed dividend – Series C redemption                                                         $ 427,000       427,000
Net loss                                                           (4,390,000)     (4,390,000)
Unrealized loss on available-for-sale securities                                                             (31,000)   (31,000)
Balance, end of period           0                         2,000                 312,214,000   (299,231,000) (80,000)   12,905,000
Total stockholders’ (deficit) equity           $ 0                         $ 2,000                 $ 312,214,000   $ (299,231,000) $ (80,000)   $ 12,905,000
[1] Fair valued based on the closing price of the Company’s common stock on the respective common stock dividend payment date.